These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
408 related items for PubMed ID: 7588299
1. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Angelloz-Nicoud P, Binoux M. Endocrinology; 1995 Dec; 136(12):5485-92. PubMed ID: 7588299 [Abstract] [Full Text] [Related]
2. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases. Angelloz-Nicoud P, Harel L, Binoux M. Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645 [Abstract] [Full Text] [Related]
3. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Lalou C, Silve C, Rosato R, Segovia B, Binoux M. Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330 [Abstract] [Full Text] [Related]
4. Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22-25-kDa proteolytic fragment (1-160) and inhibited by the 16-kDa fragment (1-95) of recombinant human insulin-like growth factor binding protein-3. Angelloz-Nicoud P, Lalou C, Binoux M. Growth Horm IGF Res; 1998 Feb; 8(1):71-5. PubMed ID: 10990447 [Abstract] [Full Text] [Related]
5. Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factor-beta and retinoic acid. Menouny M, Binoux M, Babajko S. Endocrinology; 1997 Feb; 138(2):683-90. PubMed ID: 9003003 [Abstract] [Full Text] [Related]
6. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Fowlkes J, Freemark M. Endocrinology; 1992 Nov; 131(5):2071-6. PubMed ID: 1385096 [Abstract] [Full Text] [Related]
7. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction. Salahifar H, Baxter RC, Martin JL. Endocrinology; 1997 Apr; 138(4):1683-90. PubMed ID: 9075731 [Abstract] [Full Text] [Related]
8. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells. Price WA, Moats-Staats BM, Stiles AD. Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777 [Abstract] [Full Text] [Related]
9. Proteolysis of insulin-like growth factor-binding protein-3 by human skin keratinocytes in culture in comparison to that in skin interstitial fluid: the role and regulation of components of the plasmin system. Xu S, Savage P, Burton JL, Sansom J, Holly JM. J Clin Endocrinol Metab; 1997 Jun; 82(6):1863-8. PubMed ID: 9177397 [Abstract] [Full Text] [Related]
10. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. Durham SK, Riggs BL, Conover CA. J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411 [Abstract] [Full Text] [Related]
11. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Koutsilieris M, Frenette G, Lazure C, Lehoux JG, Govindan MV, Polychronakos C. Anticancer Res; 1993 Dec; 13(2):481-6. PubMed ID: 7685989 [Abstract] [Full Text] [Related]
12. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid. Marcelli M, Haidacher SJ, Plymate SR, Birnbaum RS. Endocrinology; 1995 Mar; 136(3):1040-8. PubMed ID: 7532576 [Abstract] [Full Text] [Related]
13. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in-vitro model. Thompson MA, Cox AJ, Whitehead RH, Jonas HA. Endocrinology; 1990 Jun; 126(6):3033-42. PubMed ID: 1693565 [Abstract] [Full Text] [Related]
14. Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Kimura G, Kasuya J, Giannini S, Honda Y, Mohan S, Kawachi M, Akimoto M, Fujita-Yamaguchi Y. Int J Urol; 1996 Jan; 3(1):39-46. PubMed ID: 8646598 [Abstract] [Full Text] [Related]
15. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis. Irwin JC, Dsupin BA, Giudice LC. J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715 [Abstract] [Full Text] [Related]
16. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation. Park JH, McCusker RH, Vanderhoof JA, Mohammadpour H, Harty RF, MacDonald RG. Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441 [Abstract] [Full Text] [Related]
17. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. Ortiz CO, Chen BK, Bale LK, Overgaard MT, Oxvig C, Conover CA. J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760 [Abstract] [Full Text] [Related]
18. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Reeve JG, Morgan J, Schwander J, Bleehen NM. Cancer Res; 1993 Oct 01; 53(19):4680-5. PubMed ID: 7691401 [Abstract] [Full Text] [Related]
19. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology. Durham SK, Kiefer MC, Riggs BL, Conover CA. J Bone Miner Res; 1994 Jan 01; 9(1):111-7. PubMed ID: 7512304 [Abstract] [Full Text] [Related]
20. IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. Kaicer E, Blat C, Imbenotte J, Troalen F, Cussenot O, Calvo F, Harel L. Growth Regul; 1993 Sep 01; 3(3):180-9. PubMed ID: 7693099 [Abstract] [Full Text] [Related] Page: [Next] [New Search]